The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
基本信息
- 批准号:8013022
- 负责人:
- 金额:$ 18.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-15 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:Axillary Lymph Node DissectionCell ProliferationCellsDataDiseaseDrainage procedureExtracellular MatrixGoalsGrowthGrowth FactorHumanImplantLiquid substanceLymphLymphangiogenesisLymphaticLymphatic CapillariesLymphatic Endothelial CellsLymphedemaMediatingModelingMusNatural regenerationObstructionPhysiologicalRegulationRelative (related person)ReportingResolutionRoleSchemeSiteSkinStagingSwellingTailTestingTissuesVascular Endothelial Growth Factor Cangiogenesisarmcancer surgerycell motilitycitrate carrierclinically significantcompare effectivenessimprovedinterstitialmalignant breast neoplasmmouse modeloverexpressionpublic health relevancescaffoldwound
项目摘要
DESCRIPTION (provided by applicant): Vascular endothelial growth factor (VEGF)-C has been shown to be necessary for lymphangiogenesis and may be useful for lymphangiogenic therapy in diseases of inadequate lymphatic drainage. Although a number of recent studies have reported that overexpression of VEGF-C can promote lymphangiogenesis and improve lymphatic function, we have found that the ability of excess lymphatic growth factor alone to increase functional lymphatic growth above physiological levels may be limited. We have also found that experimental lymphedema is able to resolve in the absence of lymphangiogenesis. Clinically, compressive garments have been shown to produce significant reductions in the swelling of the edematous human arm. These results suggest that interstitial flow (IF) dynamics across the obstruction site may be important for resolution of lymphedema and that IF can be increased in the edematous arm without prior stimulation of lymphatic growth. Therefore therapies that directly increase IF may be beneficial for lymphedema. It has recently been demonstrated that fluid channels are formed by IF and that endogenous VEGF-C promotes lymphatic endothelial cell (LEC) migration along the fluid channel scaffold during early stages of lymphangiogenesis. We hypothesize that compressive loading may increase IF by increasing fluid channel formation and that combining VEGF-C therapy with compressive loading may improve functional lymphangiogenesis by convecting VEGF-C through fluid channels and establishing VEGF-C gradients that can direct functional lymphatic growth. We aim to determine whether compressive loading may increase IF by increasing the formation of fluid channels, whether an augmentation of fluid channels by compression in conjunction with exogenous VEGF-C protein may enhance functional lymphangiogenesis and improve lymphedema, and whether cyclic compressive loading may increase IF relative to static compressive loading.
PUBLIC HEALTH RELEVANCE: Lymphedema often follows axillary lymph node dissection from breast cancer surgery. Although compression therapy reduces lymphedema, the mechanism of action is not clear. We aim to clarify the role of compression in regulating interstitial flow and to determine the ability of combined compression/lymphangiogenesis therapy to improve lymphedema.
描述(由申请人提供):血管内皮生长因子(VEGF)-C已被证明是淋巴管生成所必需的,并可用于淋巴引流不足疾病的淋巴管生成治疗。尽管最近的一些研究报道过表达VEGF-C可以促进淋巴管生成和改善淋巴功能,但我们发现单独过量的淋巴生长因子增加功能性淋巴生长超过生理水平的能力可能是有限的。我们还发现,实验性水肿是能够解决在没有淋巴管生成。临床上,压缩服装已被证明产生显着减少肿胀的人arm. These结果表明,间质流(IF)动力学阻塞部位可能是重要的解决水肿和IF可以增加在水肿的手臂没有事先刺激淋巴生长。因此,直接增加IF的治疗可能对水肿有益。最近已经证明,流体通道是由IF形成的,并且在淋巴管生成的早期阶段,内源性VEGF-C促进淋巴管内皮细胞(LEC)沿流体通道支架沿着迁移。我们假设,压缩负荷可能会增加IF增加流体通道的形成,并结合VEGF-C治疗与压缩负荷可能会改善功能性淋巴管生成通过对流VEGF-C通过流体通道,并建立VEGF-C梯度,可以直接功能性淋巴管生长。我们的目的是确定是否压缩负荷可能会增加IF通过增加形成的流体通道,是否增加流体通道的压缩与外源性VEGF-C蛋白结合可以增强功能性淋巴管生成和改善水肿,以及是否循环压缩负荷可能会增加IF相对于静态压缩负荷。
公共卫生相关性:乳腺癌手术后腋窝淋巴结清扫后常出现淋巴水肿。虽然压迫疗法可以减少水肿,但其作用机制尚不清楚。我们的目的是阐明压迫在调节间质血流中的作用,并确定联合压迫/淋巴管生成治疗改善水肿的能力。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Goldman其他文献
Jeremy Goldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Goldman', 18)}}的其他基金
Biodegradable Metal Stent Alloys for Vascular Applications
用于血管应用的可生物降解金属支架合金
- 批准号:
10643743 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Biodegradation mechanism and rate, biocompatibility, and toxicity for novel Zn-Mg stent materials
新型锌镁支架材料的生物降解机制和速率、生物相容性和毒性
- 批准号:
8957197 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Therapeutic Lymphatic Collecting Vessel Regeneration by Directed Fluid Flow
通过定向流体流进行治疗性淋巴收集管再生
- 批准号:
8287227 - 财政年份:2012
- 资助金额:
$ 18.9万 - 项目类别:
The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
- 批准号:
7769809 - 财政年份:2010
- 资助金额:
$ 18.9万 - 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
- 批准号:
7141151 - 财政年份:2006
- 资助金额:
$ 18.9万 - 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
- 批准号:
7267942 - 财政年份:2006
- 资助金额:
$ 18.9万 - 项目类别:
Mechanical Stretch and Vein Graft Intimal Hyperplasia
机械拉伸和静脉移植内膜增生
- 批准号:
6952906 - 财政年份:2005
- 资助金额:
$ 18.9万 - 项目类别:
相似海外基金
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
- 批准号:
10467183 - 财政年份:2022
- 资助金额:
$ 18.9万 - 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
- 批准号:
10612928 - 财政年份:2022
- 资助金额:
$ 18.9万 - 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
- 批准号:
10796612 - 财政年份:2022
- 资助金额:
$ 18.9万 - 项目类别:
Mechanisms of Cell proliferation and tumorigenesis in ATP1A1 gene mutated adrenal cells
ATP1A1基因突变肾上腺细胞增殖及肿瘤发生机制
- 批准号:
21K16058 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Invesitigation of GLP-1 mediated pancreatic beta cell proliferation by interactions between islets and acinar cells
通过胰岛和腺泡细胞之间的相互作用研究 GLP-1 介导的胰腺 β 细胞增殖
- 批准号:
20K17516 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineering synthetic helper cells that autonomously deliver orthogonal IL-2 to selectively promote therapeutic T cell proliferation in tumors
工程合成辅助细胞可自主递送正交 IL-2 以选择性促进肿瘤中治疗性 T 细胞增殖
- 批准号:
10285941 - 财政年份:2019
- 资助金额:
$ 18.9万 - 项目类别:
HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells
HEG1 反应性 microRNA-23b 调节恶性间皮瘤细胞的细胞增殖
- 批准号:
19K07439 - 财政年份:2019
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Temporal information coding of cell proliferation inhibitory signal revealed by optical measurement and control of p38 activity in living cells
通过活细胞中 p38 活性的光学测量和控制揭示细胞增殖抑制信号的时间信息编码
- 批准号:
19K06548 - 财政年份:2019
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of platelet-activating factor (PAF)-associated cell proliferation in cancer and non-cancer cells.
阐明癌症和非癌细胞中血小板激活因子(PAF)相关细胞增殖的机制。
- 批准号:
19K10305 - 财政年份:2019
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of novel MMP-3 degrading products and investigation of cell proliferation using high purity odontoblast-like cells
使用高纯度成牙本质细胞样细胞鉴定新型 MMP-3 降解产物并研究细胞增殖
- 批准号:
15K20418 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Young Scientists (B)